Notice of Annual General Meeting

Summary by AI BETAClose X

4basebio PLC has announced its Annual General Meeting, scheduled for June 30, 2026, which will include a resolution to approve a substantial intellectual property disposal. This disposal involves transferring assets related to its "Hermes" formulation of nucleic acids in nanoparticles business to Targo TX Limited, a company owned by Heikki Lanckriet and David Roth, in exchange for a 10% stake in Targo TX Limited and a limited-use license over specific patents. The company has secured irrevocable undertakings from shareholders representing 62.73% of its ordinary share capital to vote in favor of the resolutions, and the Board unanimously recommends shareholders do the same. Additionally, the meeting will address the re-appointment of auditors, directors, and propose authorities for the allotment of shares and disapplication of pre-emption rights, with specific limits on nominal amounts and expiry dates.

Disclaimer*

Companies

4basebio (4BB)
UK 100

Latest directors dealings